Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?

Diabetes Research and Clinical Practice

Volumn 87, Issue 1, 2010, Pages 33-37

  Arababadi, Mohammad Kazemi ^a   Nosratabadi, Reza ^b   Hassanshahi, Gholamhossein ^a   Yaghini, Narges ^a   Pooladvand, Vahid ^a   Shamsizadeh, Ali ^a   Hakimi, Hamid ^a   Derakhshan, Reza ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Diabetes; IFN ; IL 17A; Nephropathy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA;

ADULT; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; IRAN; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 73749084535     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.09.027     Document Type: Article

References (27)

1. Steyn N.P., Lambert E.V., and Tabana H. Nutrition interventions for the prevention of type 2 diabetes. Proc. Nutr. Soc. 10 (2008) 1-16
2. Arababadi M.K., Naghavi N., Hassanshahi G., and Mahmoodi M. Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes?. Ann. Saudi Med. 29 5 (2009) 413
3. Nathanson D., and Nystrom T. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium. Mol. Cell. Endocrinol. 21 (2008) 21
4. Cruz M., Maldonado-Bernal C., Mondragon-Gonzalez R., Sanchez-Barrera R., Wacher N.H., Carvajal-Sandoval G., et al. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J. Endocrinol. Invest. 31 8 (2008) 694-699
5. Giulietti A., van Etten E., Overbergh L., Stoffels K., Bouillon R., and Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile, 1,25-dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res. Clin. Pract. 77 1 (2007) 47-57
6. Tsiavou A., Degiannis D., Hatziagelaki E., Koniavitou K., and Raptis S.A. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J. Interferon Cytokine Res. 24 7 (2004) 381-387
7. Skopinski P., Rogala E., Duda-Krol B., Lipinska A., Sommer E., Chorostowska-Wynimko J., et al. Increased interleukin-18 content and angiogenic activity of sera from diabetic (type 2) patients with background retinopathy. J. Diabetes Complications 19 6 (2005) 335-338
8. Pickup J.C., Chusney G.D., Thomas S.M., and Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 67 3 (2000) 291-300
9. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 5 (2002) 500-508
10. Bever Jr. C.T., Panitch H.S., Levy H.B., McFarlin D.E., and Johnson K.P. Gamma-interferon induction in patients with chronic progressive MS. Neurology 41 7 (1991) 1124-1127
11. Wong C.K., Ho A.W., Tong P.C., Yeung C.Y., Kong A.P., Lun S.W., et al. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin. Exp. Immunol. 149 1 (2007) 123-131
12. Xie H.F., Li J., and Shi W. Effect of corticosteroids on the balance of Th cytokines in patients with systemic lupus erythematosus. Hunan Yi Ke Da Xue Xue Bao 27 6 (2002) 533-535
13. Matsumoto K., and Kanmatsuse K. Increased urinary excretion of interleukin-17 in nephrotic patients. Nephron 91 2 (2002) 243-249
14. Seconi J., Watt V., and Ritchie D.S. Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant. 32 4 (2003) 447-450
15. Antonysamy M.A., Fanslow W.C., Fu F., Li W., Qian S., Troutt A.B., et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol. 162 1 (1999) 577-584
16. Hoerbelt R., Benjamin C.L., Shoji T., Houser S.L., Muniappan A., Hasse R.S., et al. The effects of tolerance on allograft damage caused by the innate immune system. Transplantation 85 3 (2008) 314-322
17. Litonjua A.A., Sparrow D., Guevarra L., O'Connor G.T., Weiss S.T., and Tollerud D.J. Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study. Ann. Allergy Asthma Immunol. 90 4 (2003) 422-428
18. Cooke A. Th17 cells in inflammatory conditions. Rev. Diabet. Stud. 3 2 (2006) 72-75
19. Ozer G., Teker Z., Cetiner S., Yilmaz M., Topaloglu A.K., Onenli-Mungan N., et al. Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings. J. Pediatr. Endocrinol. Metab. 16 2 (2003) 203-210
20. Chen J., and Liu X. The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell Immunol. 254 2 (2009) 85-90
21. Arababadi M.K., Pourfathollah A.A., Daneshmandi S., Hassanshahi G., Zarandi E.R., Shamsizadeh A., et al. Evaluation of relation between IL-4 and IFN-g polymorphisms and type 2 diabetes. IJBMS 12 2 (2009) 100-104
22. Mavridis G., Souliou E., Diza E., Symeonidis G., Pastore F., Vassiliou A.M., et al. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 18 7 (2008) 471-476
23. Moriwaki Y., Yamamoto T., Shibutani Y., Aoki E., Tsutsumi Z., Takahashi S., et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52 5 (2003) 605-608
24. Xu H., Nakayama K., Ogawa S., Sugiura A., Kato T., Sato T., et al. Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus. Nippon Jinzo Gakkai Shi 47 5 (2005) 524-530
25. Miljkovic D., Cvetkovic I., Momcilovic M., Maksimovic-Ivanic D., Stosic-Grujicic S., and Trajkovic V. Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell. Mol. Life Sci. 62 22 (2005) 2658-2668
26. Mensah-Brown E.P., Shahin A., Al-Shamisi M., Wei X., and Lukic M.L. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur. J. Immunol. 36 1 (2006) 216-223
27. Sumarac-Dumanovic M., Stevanovic D., Ljubic A., Jorga J., Simic M., Stamenkovic-Pejkovic D., et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int. J. Obes. (Lond.) 33 1 (2009) 151-156